Introduction to the history of multiple sclerosis
PDF (Español)
HTML (Español)

Keywords

Multiple Sclerosis
Ollivier d’Angers
Frerichs
Charcot
Poser
MacDonald (MeSH)

Abstract

Multiple Sclerosis (MS) was initially described in a Scandinavian document and two centuries later in the diary of a Dutch Saint. Long after, at the beginning of the eighteenth century, an isolated case was reported and it was not until the nineteenth century that cases were most frequently reported. During the first half of this century a patient was referenced, for the first time, in the medical literature and two atlas of pathology reported the disease. Thereafter, during the second half of the nineteenth century, the modern conception of MS is developed, based on the stories of Frerichs, in Germany, and later Charcot’s, head of the Pitié-Salpêtrière. However, it was during the past century that MS reached maturity with the emergence of the diagnostic criteria, the concept of remyelination, neuroimage and pharmacological treatment. In the XXI century, based on technological advancement and a better understanding of the disease, new diagnostic criteria are proposed as well as alternative therapies and oral monoclonal antibodies. In this century, advances in genetics represent a great challenge, as well as biomarkers and more medications of a wider effectiveness

https://doi.org/10.22379/2422402217

PDF (Español)
HTML (Español)

References

SAN TORLAKR. ODDAVERJA-ÞÁTTR. The Second Life of Thorlac. Icelandic-English. In: Origines Islandicae. A collection of the more important sagas and other native writings relating to the settlement and early history of Iceland. Edited and translated by Gudbrand Vigfusson and F. York Powel. Volume I. Oxfort at the Clarendon Press; 1905. P. 567-591.

COMPSTON DA, EBERS GC. The genetics of multiple sclerosis. In: Handbook of neurology, eds. Cook SD. Decker-New York; 1990. P. 25-39.

ALBERS P.- ST LIDWINA. In: Catholic Encyclopedia. London UK. Encyclopedia Press Inc; 1913.

GOUGH, R. Antiquityes and Memoyres of the Parish of Myddles, County of Salop; 1700.

FIRTH D. The case of Augustus d'Esté. Cambridge. Book Reviews; 1948.

ODED A. On Receiving the Heinrich Heine Award. Department of Neurology, Hadassah-Hebrew University Medical Center. Jerusalem- Israel. Dusseldor IMAJ. 2009, Sept.; 11.

BATHURST B. The Lighthouse Stevensons. Harper Perennial; March 2005.

CHAMBERS TK. Lecture XXIX on Muscular Atrophy. The Lancet. 1864: 347.

MURRAY, J. Multiple Sclerosis. The history of a disease. Library of Congress. Cataloging in Publication Data. Demos Medical Publishing. New York; 2005.

OLLIVIER D'ANGERS CH. Maladies de la Moelle Epiniére; 1824.

CARSWELL R. Illustrations of the Elementary Forms of Disease. London. Longman; 1838: Pl1V, fig 1.

CRUVEILHIER J. L'Anatomie pathologique du corps humain; descriptions avec figures lithographiées et coloriées: diverses alterations morbides dont le corps humain est susceptible. Paris, Baillière. 1829-1842; Vol 2, liv 32, Pl 2, pp 19-24; liv 38, Pl 5:1-4.

FRERICHS FT. Über Hirnsklerose. Arch Ges Med. 1849; 10: 334-337.

PEARCE JM. Historical Descriptions of Multiple Sclerosis. Eur Neurol. 2005; 54:49-53.

CLARKE E, O´MALLEY, CH, The Human Brain and Spinal Cord: A Historical Study Illustrated by Writings. Norman Publishing, Second Edition, San Francisco, CA; 1996.

RUMPLER H, DENK H(HGG), OTNERR CH. Carl Freiherr von Rokitansky (1804-1878): Pathologe, Politiker, Philosoph. Grunder der Wiener Medizineschen. Schules des 19 Jarhunderst- Munken; 2005.

RINDFLEISCH E. Histologisches Detail zu der grauen Degeneration von Gehirn undRückenmark. Zugleich ein Beitrag von der Entstehung und Verwandlung der Zelle. Archiv für pathologische Anatomie und Physiologie und für klinische Medizin. 1863; 26:474-483.

VIETS HR. Moritz Heinrich Romberg (1795-1873). In: The Founders of Neurology. Clin Anat. 2014; 27(2): 147-9.

GREEN, JH. Marshall Hall (1790-1857): A biographical Study. Medical History. Apr 1958; 2(2): 120.

HAMMOND, WA. Treatise on disease of the Nervous System, 1st ed. New York. D. Appleton, 1871.

CHARCOT JM. Histiologie de la sclerose en plaques. Gaz Hop. 1868; 41:554-555.

DUBB A. Jean-Martin Charcot (1825-1893): his life and his legacy. Adler Mus Bull. 1993; 19(3):19-24.

CHARCOT JM. Lecons sur les maladies du système nerveus faites à la Salpetrière, 1877.

MURRAY, J. The history of multiple sclerosis: the changing frame of the disease over the centuries. Journal of Neuriological Science. 2009; 277, suppl. 1: S3-S8.

JAY V. The legacy of Jean-Martin Charcot. Arch Pathol Lab Med. 2000; 124:10-11.

PEARCE JM. Edme Felix Alfred Vulpian (1826-1887). J Neurol. 2002; 249 (12): 1749.

COMPSTON A. The story of multiple sclerosis. In: McAlpine's Multiple Sclerosis Chapter 1. Fourth Edition. Elsevier, 2006.

BARBELLION, WN (pseudonym of Cummming, BF). The Journal of a Disappointed Man.London; Chatto an Windus, 1919.

DEVIC E. Myelite subaiguë compliquée de névrite optique. Bull Med. 1894; 8:1033-1034.

GAULT F. De la neuromyélite optique aiguë. Thèse no 891, Faculté de Médecine et de Pharmacie de Lyon.

LHERMITTE J, BOLLAK A, NICHOLAS M. Les douleurs a type de decharge electrique consecutives a la Flexion cephalique dans la sclerose en plaques. Un cas de forme sensitive de la sclerose multiple, Revue Neurologique. 1924 ; 2:56-62.

WECHSLER, I. A Textbook of Clinical Neurology. W. B. Saunders Company; Eighth Edition, 1958.

BRAIN WR. Critical review: disseminated sclerosis. Q J Med. 1930; 23:343-391.

WEKERLE H, KOJIMA K, LANNES-VIEIRA J, LASSMANN H, LININGTON C. Animal models. Ann Neurol. 1994; 36:S47-S53.

POSER C, PATY D, SCHEINBERG L, ET AL. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13:227-31.

RUDICK RA, WHINTAKER JN. Cerebrospinal fluid tests for multiple sclerosis. In: Scheinberg Eds. Neurology/ Neurosurgery. 1987; 7.

ALLISON R, MILLARD J. Prevalence and familial incidence of disseminated sclerosis. Ulster Med J. 1954; 23 (suppl 2): 1-92.

PERIER O. GREGOIRE A. Electron microscopic features of multiple sclerosis lesions. Laboratoire d'Anatomie pathologique et centre de Microscopie Electronique, Faculté de Médicine de l'Université Libre de Bruxelles. Brain. 1965; 88: 937-952.

SCHUMACHER G, BEEBE G, KIBLER R, KURLAND L, KURTZKE J, MC DOWEL F, ET AL. Problems of experimental trials of therapy in Multiple Sclerosis. Ann NY Aca Sci. 1965; 122: 552-568.

MILLER H, NEWELL DJ, RIDLEY A. Multiple sclerosis: treatment of acute exacerbations with corticotropin (ACTH). Lancet. 1961; 2: 1120-2.

ROSE AS, KUZMA JW, KURTZKE JF, NAMEROW NS, SIBLEY WA. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH versus placebo: final report. Neurology. 1970; 20: 1-59.

MCALPINE, LUMSDEN C, ACHESON E (eds). Multiple Sclerosis: a reppraisal. Baltimore: Williams and Wilkins; 1972: 225-226.

PRINEAS JW, WRIGHT RG. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 1978; 38: 409-421.

SÁNCHEZ-MÚNERA, J.- Criterios diagnósticos en esclerosis múltiple. VI Congreso Colombiano de Neurología - Ponencia. Acta Neurol Colomb. 2003, Sept.; 19 (3).

YOUNG, IR ET AL. Nuclear magnetic resonance imaging of the brain in Multiple Sclerosis. The Lancet. 1981, Nov 14:1063-65.

GROSSMAN RI ET AL. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology. 1986; 161:721-725.

FAZEKAS F, OFFENBACHER H, FUCHS S, SCHMIDT R, NIEDERKORN K, HORNER S, ET AL. Criteria for an increased specifity of MRI interpretation in elderly subjects with suspected MS. Neuroloy. 1988; 38: 1822- 1825.

PATY D, NOSEWORTHY J, EBERS G. Diagnosis of multiple sclerosis. In: Paty D, Ebers G, editors. Multiple sclerosis. Philadelphia: F.A. Davis Co; 1998. p.73.

GOODKIN DE, DOOLITTLE TH, PA-C, HAUSER S, RAMSOHOFF RM, ROSES AD, RUDICK RA. Diagnostic criteria for Multiple Sclerosis research involving multiply affected families. Arch Neurol. 1991; 48: 805-807.

BARKHOF F, FILIPPI M, MILLER D, SCHELTENS P, CAMPI A, POLMAN C, ET AL. Comparison of MRI criteria at first presentation to predict conversion to clinically definite Multiple Sclerosis. Brain. 1997; 120:2059- 2069.

TINTORE M, ROVIRA A, MARTINEZ M, ET AL. Isolated demyelinating syndromes:comparison of different MR imaging criteria to predict conversion to clinically definite MS. Am J Neuroradiol. 2000; 702-706.

PRESTON GM, CARROLL TP, GUGGINO WB, AGRE P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science. 1992; 256:385-387.

Inland Empire Health Plan (IEHP). Clinical Practice Guideline for the Diagnosis ant Management of Multiple Sclerosis. Disease Modifying Therapies in Multiple Sclerosis. Adopted from the Report of The Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and The MS Council for Clinical Practice Guidelines- Endorsed by the American Academy of Neurology. 2014; November, 12.

The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing remitting-multiple sclerosis: I. Clinical results of a multicenter, randomized, double blind, placebo-controlled trial. Neurology. 1993; 43:655-661.

PATY DW, LI DK. THE UBC MS/MRI STUDY GROUP, THE IFNB MULTIPLE SCLEROSIS STUDY GROUP. Interferon beta-1b is effective in remitting and relapsing multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993; 43:662-667.

JACOBS L, ET AL. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science. 1981; 214(4524):1026-1028.

KRAKAUER M, SCHALDEMOSE-NIELSEN H, JENSEN J, SELLEBJERG F. Intrathecal synthesis of free immunoglobulins light chains in multiple sclerosis. Acta Neurol Scand. 1998; 98: 161-165.

MC DONALD WI, ET AL. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001; 50:121-127.

LENNON VA, WINGERCHUK DM, KRYZER TJ, PITTOCK SJ, LUCCHINETTI CF, FUJIHARA K, ET AL. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004; 364:2106-2112.

POLMAN CH, REINGOLD SC, BANWELL B, ET AL. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69:292-302.

FREEDMAN M, ET AL. Treatment Optimization in MS: Canadian MS. Working Group Update Recommendations. Can J Neurol Sci. 2013; 40:307-323.

FERNÁNDEZ-LIGUORI N, SEIFER G, VILLA A, GARCEA O. Fingolimod, un nuevo enfoque en el tratamiento de la esclerosis múltiple. Neurología Argentina. 2012, Julio-Septiembre; 04 (3).

SHACKELFORD K. Overview of current treatment options for MS. Multiple Sclerosis: Treatment Guidelines. Healthline, 2013.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.